| 1 |
34493714 | Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. | 2021 Sep 7 |
1 |
| 2 |
31105821 | Sitagliptin protects against hypoxia/reoxygenation (H/R)-induced cardiac microvascular endothelial cell injury. | 2019 |
1 |
| 3 |
28721055 | Chitosan oligosaccharide improves the therapeutic efficacy of sitagliptin for the therapy of Chinese elderly patients with type 2 diabetes mellitus. | 2017 |
1 |
| 4 |
26546612 | Effects of sitagliptin on circulating zinc-α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial. | 2016 Feb |
1 |
| 5 |
27199127 | The contributions of dipeptidyl peptidase IV to inflammation in heart failure. | 2016 Jun 1 |
1 |
| 6 |
23062489 | A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. | 2013 Mar |
2 |
| 7 |
23187735 | GLP-1-dependent and independent effects and molecular mechanisms of a dipeptidyl peptidase 4 inhibitor in vascular endothelial cells. | 2013 Mar |
2 |
| 8 |
23805228 | Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes. | 2013 |
1 |
| 9 |
21382532 | Inhibition of anaphylaxis like reaction and mast cell activation by Sitagliptin. | 2011 Aug |
1 |